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Abstract 
Twenty years ago Human tuberculosis (TB) was thought to be a disease on the verge of 
eradication. Nowadays TB is one of the deadliest diseases in the world and the WHO 
estimates that more than one-third of the world’s population is infected with TB. 
Maltokinase (Mak) is an enzyme essential for mycobacterial growth that is present in 
nearly all mycobacterial genomes. Nonetheless the physiological role of this enzyme 
remains to be fully elucidated. 
In an effort towards unveiling the role of Mak in mycobacterial physiology additional 
functions of the enzyme in vitro were explored, namely by testing possible alternative 
substrates (phosphoryl acceptors) as well as the possibility of the involvement of this 
enzyme in the inactivation of aminoglycoside antibiotics. A preliminary analysis of the 
transcriptional responses of the corresponding gene in M. smegmatis, in different 
nutritional conditions, was attempted. Concurrently, to confirm the proposed 
essentiality of Mak, M. marinum was selected as the tool for the construction of a mak 
conditional knock-out mutant, and thus, evaluate the effects of silencing the gene on the 
mutant’s phenotype. 
Recombinant His-tagged Mak was purified to further test substrate specificity. The 
purification protocol was made less laborious by the modification of the sodium 
phosphate buffer pH. Subsequently several substrates were tested as phosphoryl group 
acceptors Namely aminoglycoside antibiotics, disaccharides and trisaccharides, 
however no activity was detected, except for maltose, implicating that in M. smegmatis 
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the role of phosphate acceptor might be specific to maltose. It is then extremely unlikely 
the protein could render aminoglycoside resistance to bacteria. 
To evaluate the relation between mak expression and the nutritional source in the 
growth medium the activity of the enzyme was determined in M. smegmatis cell-free 
extracts. The results indicate that Mak activity is significantly affected by the presence 
of maltose in the medium. In order to analyze the transcriptional responses of the mak 
gene in different nutritional conditions an RT-PCR experiment was optimized but due 
to technical problems and time constraints, no further progress could be made beyond 
this stage. 
The design and construction for the engineering of the mak conditional mutant done in 
this work will, in the future, allow the conditional expression of genes essential for 
mycobacterial growth and in doing so, provide a better understanding of their 
involvement in mycobacterial metabolism. 
 
Keywords: maltokinase, maltose-1-phosphate, mycobacteria, metabolism, RT-PCR.  
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Resumo 
Há cerca de vinte anos pensava-se que a tuberculose era uma doença em vias de 
erradicação no entanto, hoje em dia, é uma das doenças mais mortíferas do mundo. A 
Organização Mundial de Saúde estima que mais de um terço da população mundial 
esteja infectada com tuberculose. 
A maltocinase (Mak) é uma enzima essencial para o crescimento micobacteriano que se 
encontra presente na maioria dos genomas micobacterianos anotados. Contudo, o papel 
fisiológico desta enzima ainda não é totalmente conhecido. 
Numa tentativa de elucidar o papel desempenhado pela Mak na fisiologia 
micobacteriana foram, neste trabalho, exploradas funções adicionais da proteína, in 
vitro. Foram testados substratos alternativos (aceitadores de grupo fosforil), bem como a 
possibilidade de a enzima estar envolvida na inactivação de antibióticos 
aminoglicosídeos. Foi ainda realizado um ensaio preliminar para análise das respostas 
transcripcionais do gene correspondente em M. smegmatis, em diferentes condições 
nutricionais. Simultaneamente, para confirmar o papel essencial proposto para a Mak, o 
organismo M. marinum foi seleccionado, como ferramenta para construção de um 
mutante knock-out condicional para mak, para deste modo avaliar os efeitos do 
silenciamento do gene no fenótipo do mutante. 
A proteína recombinante, com cauda de histidinas, foi purificada com vista a serem 
efectuados testes de especificidade de substratos. O protocolo de purificação foi 
modificado, através da alteração do pH do tampão fosfato de sódio, de modo a encurtar 
a duração da purificação. Em seguida, vários substratos foram testados como 
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aceitadores de grupos fosforil, nomeadamente antibióticos aminoglicosídeos, 
dissacarídeos e trissacarídeos. No entanto, não foi detectada qualquer actividade, 
excepto para a maltose, o que implica que em M. smegmatis o papel de aceitador de 
grupos fosfatos deve ser específico para este açúcar. É pois extremamente improvável 
que a proteína Mak confira resistência a aminoglicosídeos. 
Para avaliar a relação entre a expressão do gene mak de M. smegmatis e diferentes 
fontes de carbono no meio de cultura, determinámos a actividade da enzima em 
extractos celulares de M. smegmatis. Os resultados indicam que a actividade da Mak é 
significativamente afectada pela presença de maltose no meio. Com o objectivo de 
analisar as respostas trascripcionais do gene mak em diferentes condições nutricionais 
uma experiência de RT-PCR foi optimizada. No entanto, devido a uma série de 
problemas de ordem técnica e limitações a nível temporal, não foi possível progredir 
para além do que é apresentado neste trabalho. 
O desenho e construção para a criação do mutante condicional para a mak apresentado 
neste trabalho vão permitir, futuramente, a expressão condicional de genes essenciais ao 
crescimento micobacteriano, permitindo deste modo um melhor entendimento do seu 
envolvimento no metabolismo destas bactérias. 
Palavras-chave: maltocinase, maltose-1-fosfato, micobactéria, metabolismo, RT-PCR 
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1. Tuberculosis 
1.1. Tuberculosis’ Occurrence 
Human tuberculosis (TB) is one of the deadliest diseases in the world despite the 
multitude of strategies to prevent and control the disease. The World Health 
Organization (WHO) estimates more than one-third of the world’s population to be 
infected with TB (first contact). In 2008 this disease took more than 1.8 million lives 
(WHO report 2009). TB is also one of the leading causes of death among HIV infected 
people. 
Twenty years ago TB was thought to be a disease on the verge of eradication. The 
problem, however, has become more severe. Not only due to the synergy between 
HIV/AIDS and tuberculosis or the combination of the HIV epidemic with an urban drug 
problem, but also owing to the lack of drug compliance and subsequent appearance of 
multiple-drug-resistant strains (MDR-TB), in addition to the inadequacy of access to 
proper medical care in developing countries. This scenery provided fertile ground on 
which tuberculosis could flourish anew (Saviola & Bishai 2006; WHO report 2009).  
In 2007 there were 9 million TB case notifications, 5 thousand of which were estimated 
to be new MDR-TB cases (resistance to standard first-line drugs) (TB fact sheet 2009) 
and recent numbers indicate that XDR-TB cases (resistance to second-line drugs in 
addition to MDR-TB) comprise 15% of MDR-TB cases (XDR TB fact sheet). 
The incidence of atypical mycobacterial infections has also increased in recent years. 
Opportunistic diseases caused by the Mycobacterium avium complex (MAC) were 
uncommon prior to the onset of the AIDS epidemic. Nowadays they remain a leading 
cause of mortality among HIV-infected people (Center for Disease Control and 
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Prevention’s (CDC) Guidelines for Prevention Treatment of Opportunistic Infections in 
HIV-Infected Adults and Adolescents, 2009). 
Global efforts to control TB were reinvigorated in 1991, when a World Health 
Assembly (WHA) resolution recognized TB as a major global public health problem, 
afterwards in 1993 the WHO declared tuberculosis a global health emergency and since 
then stopping TB has been an ongoing challenge undertaken by many organizations. 
1.2. The Genus Mycobacterium 
For many years the causative agent of tuberculosis remained a mystery as did the 
etiology of the disease. In 1868 Jean Antoine Villemin publishes “Etudes sur la 
tuberculose”, the results of the first experimentations in the field, in which he verified 
that the disease was in fact transmissible. Nonetheless mycobacteria were discovered 
only a decade later when Robert Koch isolated the Tubercle bacilli. The German 
physician presented his discovery of Mycobacterium tuberculosis in a lecture in 1882 
and later in a German medical journal the Berliner Medicinische Wochenschrift under 
the title "Die Aetiologie der Tuberculose". A few years later, Armauer Hansen 
identified the bacillus responsible for leprosy (Tan & Graham, 2008). 
In 1896 a new classification to these organisms, the genus Mycobacterium, is proposed 
by Lehmann and Neumann, it would include these species 
(http://www.bacterio.cict.fr/m/mycobacterium.html), now renamed Mycobacterium 
tuberculosis and Mycobacterium leprae. The organisms were included in the 
Mycobacteriaceae family, sub-order Corynebacterineae, order Actinomycetales and 
class Actinomycetes. The order Actinomycetales is part of a larger group, the Gram-
positive bacteria with a high G+C content, or Actinobacteria. Within the suborder 
  Introduction 
14 
 
Corynebacterineae there are eight groups of great clinical or environmental importance 
such as Corynebacterium, Nocardia and Rhodococcus (Zhi et al., 2009). 
Currently, the minimal criteria that allow inclusion in the genus Mycobacterium dictate 
that the species must be acid fast, following Ziehl-Neelsen staining; it must contain 
mycolic acids of 60–90 carbon atoms in length and its genome must have a G+C 
content of 61–71%. According to J.P. Euzéby (http://www.bacterio.cict.fr/) there are 
148 species of Mycobacterium that fit these criteria and are shown to be closely related 
through 16s ribosomal RNA (rRNA) gene analysis (Tortoli, 2006; Sidders & Stoker, 
2007). 
Based on their generation or duplication time mycobacteria can be divided into two 
groups, the slow growing mycobacteria and the fast growing mycobacteria. M. 
tuberculosis, a slow grower, has a generation time, in vitro, of about 20 hours 
(Hiriyanna & Ramakrishnan, 1986); while the generation time for M. smegmatis, a fast 
grower, is circa 3 hours (Hiriyanna & Ramakrishnan, 1986). Traditionally, they are 
distinguished by their ability to produce visible colonies on solid media within 7 days. 
Fast growing mycobacteria need up to seven days whereas slow growing mycobacteria 
need more than seven days (Sidders & Stoker, 2007). 
Most pathogenic mycobacteria are slow growers, although there are exceptions, such as 
the Mycobacterium fortuitum group, the M. chelonae/abscessus group, and the M. 
smegmatis group. These organisms comprise a group of rapidly growing mycobacteria 
that are found in soil samples as well as in water. Outbreaks are often associated with 
health care-associated infections and usually occur after a traumatic injury followed by 
potential soil or water contamination (Brown-Elliot & Wallace Jr, 2002). Furthermore 
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for immunocompromised individuals even nonpathogenic Mycobacterium species may 
become pathogenic (Shinnick & Good, 1994; Sidders & Stoker, 2007). 
The Mycobacterium avium complex (MAC) currently includes eight slow growing 
mycobacterial species. Mycobacterium avium, M. intracellulare, M. chimaera, M. 
colombiense, M. arosiense, M. bouchedurhonense, M. marseillense and M. timonense. 
In humans, as previously stated, these organisms are the cause of opportunistic 
infections (Cayrou et al., 2010). 
The mycobacteria that cause human tuberculosis are grouped together in what is known 
as the M. tuberculosis complex: it includes M. tuberculosis, M. bovis, M. caprae, M. 
africanum, M. microti, M. pinnipedii and M. canettii 
(http://www.uniprot.org/taxonomy/77643; Aranaz et al., 2003). 
Mycobacterium tuberculosis is an obligate pathogen which causes tuberculosis in 
humans and the most studied of all mycobacteria (Glickman & Jacobs Jr., 2001). 
1.2.1. Mycobacterium marinum 
In 1926, Aronson isolated and described a mycobacterium responsible for the death of 
saltwater fish in the Philadelphia aquarium. The pathogen caused a tuberculosis-like 
disease in fish. He named that organism Mycobacterium marinum (Gluckman, 1995). 
M. marinum’s optimal growth temperature is 25-35 ºC and its generation time is 
approximately 4.5 hours (Clark & Shepard, 1963). This pathogen is adapted to infect 
ectotherms. Its low optimal growth temperature most likely explains the limitation of its 
infection ability to human hosts’ extremities. The infection caused by M. marinum is 
named fish tank granuloma or swimming pool granuloma. Pathologically, the 
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granuloma caused by M. marinum dermal infection is similar to that caused by M. 
tuberculosis lung infection (Stamm & Brown, 2004). 
M. marinum is photochromogenic, producing a characteristic yellow color when 
exposed to light. The expression of pigmented molecules like carotenoids is believed to 
confer resistance to UV damage (Stamm & Brown, 2004). 
The pathological similarity of M. marinum to M. tuberculosis infection combined with 
its increased safety (biosafety level 2), more rapid growth and easier use, makes M. 
marinum an useful model with which to study pathogenic mycobacteria. M. marinum is 
also widely used to elucidate mycobacterial molecular mechanisms. Despite the obvious 
utility of the model, it is crucial to remember it carries unique adaptations and a direct 
comparison with M. tuberculosis will reveal both shared and divergent pathways. 
Tønjum et al. (1997) once having analyzed the 16s rRNA sequences of nineteeen 
mycobacterial species concluded that M. marinum, followed by M. ulcerans, are the two 
mycobacterial species outside the M. tuberculosis complex most closely related to M. 
tuberculosis. This result is supported by DNA-DNA hybridization studies. In addition 
studies conducted by Stinear et al. (2008) state that there is a M. marinum ortholog for 
80% of all coding sequences in M. tuberculosis, with an average shared amino acid 
identity of 85%. 
The complete genome sequence of M. marinum was determined by Stinear et al. (2008). 
The authors compared the organism’s genome with further mycobacterial genomes, 
among them the M. tuberculosis genome. M. marinum comprises a 6.6 Mb circular 
chromosome, the size discrepancy comparatively to M. tuberculosis’ genome (4.4 Mb 
Cole et al., 1998) reflects M. marinum´s larger host range and environmental niche. The 
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authors hypothesize that the genome comparison data indicate that M. marinum and M. 
tuberculosis have diverged from a common generalist environmental Mycobacterium 
with M. marinum retaining genes required for its dual lifestyle and M. tuberculosis 
undergoing reductive evolution, compatible with adaptation to its decreased niche. The 
same explanation is provided for the fact that whole genome comparisons between M. 
tuberculosis, M. marinum and M. smegmatis reveal a higher level of colinearity, 
synteny, and conservation of chromosome size between M. marinum and the distant 
saprophyte M. smegmatis (76% average amino acid identity) than with M. tuberculosis.  
1.2.2. Mycobacterium smegmatis 
In 1884 Lustgarten reported he had found a bacillus similar to the Tubercle bacilli in 
shyphilic chancres and gummae. Subsequently Alvarez and Tavel found the same 
organisms in normal genital secretions (smegma) of a patient with a penile ulcer 
(Wallace Jr. et al., 1988).  
M. smegmatis is altogether a rapidly growing ubiquitous saprophyte and the few related 
diseases are most commonly encountered in clinical practice. The organism can cause 
soft tissue infection, post-traumatic wound infections and surgical wound infections. As 
previously stated these healthcare-associated infections are frequently a result of direct 
traumatic inoculation of contaminated material (Brown-Elliot & Wallace Jr, 2002). 
The study of M. tuberculosis using M. smegmatis as a model system has some 
disadvantages. One of its major inconveniences is the evolutionary distance between M. 
smegmatis and M. tuberculosis which is far greater than between M. tuberculosis and 
the other commonly utilized models (such as M. marinum or M. bovis). M. smegmatis 
has a 6.98 Mb genome (http://cmr.jcvi.org/tigr-scripts/CMR/shared/Genomes.cg) 
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significantly differing from M. tuberculosis’ genome size (4.4 Mb; Cole et al., 1998) 
which, as previously explained, reflects its broader environmental niche and saprophytic 
lifestyle. Furthermore M. smegmatis has none of the pathogenic properties described for 
M. tuberculosis. On the other hand, M. smegmatis is a particularly appealing model for 
mycobacterial study because of its rapid growth and ease of genetic manipulation. M. 
smegmatis mc
2
155, the most commonly used laboratory strain, is considered a 
nonpathogenic mutant of the parental strain mc
6
. It can be readily transformed with 
foreign DNA using electroporation, making it extremely useful for expressing 
mycobacterial genes. Mutations in the M. smegmatis’ genes can be readily 
complemented with genes from M. tuberculosis, thus proving it can be a valuable 
surrogate host (Snapper et al., 1990; Gupta & Chatterji, 2005; Shiloh & Champion, 
2010). 
The conclusion to be drawn from the previous statements is that M. smegmatis is an 
extremely helpful model for comparative biology and genetic studies although it lacks 
credibility as an infection model.  
2. The Importance of Trehalose 
Sugars are fundamental to life. Sugars are an immediate and transportable energy 
source. They can also furnish structural components as well as play a role as chemical 
messengers conveying information. The structural versatility of carbohydrates provides 
the potential for a communication system, or glycocode (Paul et al., 2008). 
Trehalose is a sugar significant for its protective ability. It is a known compatible solute 
under osmotic stress, stable and with low reactivity (being a non reducing sugar). It 
protects proteins and membranes from denaturation by replacing water and during 
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desiccation trehalose prevents protein aggregation and free radical diffusion. It may 
even have a role as a signaling molecule coordinating metabolism (Woodruff et al., 
2004; Pan et al., 2004; Paul et al., 2008). 
Trehalose is an ubiquitous glucose disaccharide prevalent in mycobacteria, not only in 
the free form in the cytoplasm but also as a basic component of a number of cell wall 
glycolipids (Elbein et al., 2003). 
A distinctive characteristic of the Mycobacteriaceae family closely related with its 
pathogenic capability is its unique cell wall. The mycobacterial cell wall consists of an 
inner layer and an outer layer. The inner compartment comprises peptidoglycan (PG), 
arabinogalactan (AG) and mycolic acids (mycolic acids are β-hydroxy fatty acids with a 
long α-alkyl side chain (cf. Fig. 1)) covalently linked to form a complex that extends 
from the plasma membrane outward in layers (cf. Fig. 2). This insoluble complex causes 
the bacteria to be impervious to a great number of chemical compounds and is in part 
responsible for its resistance to most common antibiotics (Cole et al. 1998; Sidders & 
Stoker, 2007; Hett & Rubin, 2008). The outer layer, or capsule, is composed by 
carbohydrates, proteins and lipids, organized as a bilayer structure. These outer proteins 
and lipids are soluble components of the cell wall and have been referred to as the 
signaling and effector molecules of mycobacteria because of their known roles in 
interacting with the immune system (Hett & Rubin, 2008; Hoffmann et al., 2008). 
 
Figure 1 - Chemical structures of mycolic acid from M. tuberculosis. 
Adapted from Takayama et al. (2005) 
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Figure 2 - Schematic representation of the basic components of the 
mycobacterial cell wall. Adapted from Hett & Rubin (2008) 
 
The most common cell wall trehalose lipid is cord factor, or trehalose-dimycolate 
(TDM). This lipid is considered to be closely associated with mycobacterial toxicity 
(Elbein et al., 2003). 
2.1. Mycolic Acids 
In mycobacteria Fatty Acid Synthetase I and II (FAS) are multi-enzyme complexes 
involved in mycolic acid biosynthesis (Takayama et al., 2005). 
Once the mycolic acid is synthesized it needs to be processed. This three step process 
consists of the transport of the mycolate outside the cell and linkage to the PG-AG 
complex, to yield TDM. The first reaction, transfer of the mycolyl group to treahalose-
6-phosphate (T6P) to yield TMM-phosphate (trehalose-monomycolate-phosphate), is 
followed by dephosphorylation of this product. The outcome, TMM, is then transported 
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outside the cell outer membrane where it is involved in the synthesis of both TDM and 
cell wall arabinogalactanmycolate (Takayama et al., 2005). 
Mycobacteria produce two unusual polymethylated polysaccharides (PMPS) the 
methylmannose polysaccharide (MMP) and the methylglucose lipopolysaccharide 
(MGLP). Both polysaccharides are thought to regulate fatty acid synthesis by FAS-I as 
a consequence of their ability to form stable complexes with fatty acids and acyl 
coenzyme. Among other functions PMPS were also proposed to serve as general lipid 
carriers facilitating the synthesis of the very large and insoluble mycolic acid esters 
(Jackson & Brennan, 2009). 
The advantage of forming a TMM-phosphate intermediate rather than TMM directly 
from trehalose is not clear. Although being somewhat controversial, studies demonstrate 
that only T6P, but not trehalose, can stimulate mycolate production (Shimakata & 
Minatogawa, 2000) anticipating a possible role as a signaling molecule for T6P. Also a 
contentious issue is the final steps of mycolate biosynthesis.   
Tropis et al. (2005) contradict this model suggesting that mycolic acid biosynthesis 
takes place in cellular compartments other than the cytoplasm. The evidence supporting 
this statement is that Corynebacterium glutamicum mutants lacking the ability to 
produce trehalose could produce TMM, after being rescued with extrinsic trehalose and, 
most importantly, the sugar was not transported inside the cell (verified by radio 
labeling). The authors also constructed knock-out mutants for the synthesis of T6P and 
did not find differences in mycolate content, when compared to bacteria capable of 
synthesizing T6P, which lead them to state that T6P has no significant role in mycolic 
acid synthesis. 
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2.2. Biosynthetic Pathways 
Most mycobacteria have three trehalose biosynthetic pathways, M. tuberculosis, M. 
marinum and M. smegmatis are no exception (De Smet et al., 2000; Woodruff et al., 
2004; Tropis et al., 2005). The same three pathways were also found in C. glutamicum 
genome. However, while in M. smegmatis (Woodruff et al., 2004) and M. tuberculosis 
(Murphy et al., 2005) trehalose synthesis is essential for bacterial growth, the same is 
not true for Corynebacterium. In these organisms it is possible to construct viable 
knock-out mutants for all three biosynthetic pathways (Tropis et al., 2005). 
Trehalose biosynthetic pathways are named after the corresponding genes OtsAB (or 
Tps/Tpp), TreYZ and TreS. 
The OtsAB pathway catalyzes the transfer of glucose from UDP-glucose to glucose-6-
phosphate (glucose 6P) to produce UDP plus T6P, which is subsequently 
dephosphorylated into trehalose. The reactions are catalyzed by trehalose 6-phosphate 
synthase (Tps or OtsA) and trehalose 6-phosphate phosphatase (Tpp or OtsB) (cf. Fig. 
3), in E. coli these enzymes are called OtsA and OtsB (osmotically-regulated trehalose 
synthesis) (De Smet et al., 2000; Elbein et al., 2003; Tropis et al., 2005). 
The TreYZ pathway for trehalose synthesis uses oligo/polymaltooligodextrins or 
glycogen as substrate. The terminal α -1,4 glycosidic bond at the reducing end of the 
polymer is converted into α -1,1 by maltooligosyltrehalose synthase (TreY) and the 
resulting terminal trehalosyl unit of the polysaccharide is then released by 
maltooligosyltrehalose hydrolase (TreZ) (cf. Fig. 3)(De Smet et al., 2000; Elbein et al., 
2003; Tropis et al., 2005). 
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The TreS pathway is able to interconvert maltose into trehalose. The reaction is 
catalyzed by trehalose synthase (TreS), which converts the α -1,4 glycosidic bond of 
maltose into an α -1,1 linkage to yield trehalose. TreS is also capable of functioning in 
the reverse direction although (cf. Fig. 3) it shows more affinity to the conversion of 
maltose to trehalose (maltose Km=10 mM; trehalose Km=90 mM) (Pan et al., 2004). 
Pan et al. (2008) suggest that TreS has two different active sites. One is responsible for 
the maltose trehalose interconverting activity (MTase) (Pan et al., 2004) and the other 
for the amylase activity, which can produce maltose from either glycogen or 
maltooligosaccharides (cf. Fig. 3) (demonstrated in the former paper). The authors 
propose that TreS plays a key role in the interaction between trehalose and glycogen, 
when cytoplasmic trehalose levels are low, by catalyzing the conversion of glycogen to 
maltose and maltose to trehalose. Interestingly, the authors observed that high levels of 
trehalose in the cytoplasm also appeared to cause or stimulate the accumulation of 
glycogen in these cells. Subsequently Elbein et al. (2010) partially purified the enzyme 
GMPMT (α1,4-glucan: maltose-1-phosphate maltosyl-transferase) (or GlgE Kalscheuer 
et al., 2010) which is involved in the last steps of the conversion of trehalose to 
glycogen. The authors hypothesize that the enzyme might also function as a sensor or 
regulator of trehalose levels within the cell. As such, TreS can expedite the conversion 
of excess trehalose to glycogen when trehalose levels become dangerously high. From 
an energetic perspective this would be the most viable option. Although cells can 
convert trehalose to glucose, glucose can not be stored and energy would be lost. In 
stressful situations, for example after heat stress, trehalose levels would be high and 
ATP levels would likely be below inhibitory concentration (GMPMT is inhibited by 
physiological levels of ATP). Under these conditions, the maltosyl transferase pathway 
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would be activated and the excess trehalose could be converted to glycogen and stored 
for future use. Thus, the authors postulate that the major role of this pathway may be to 
convert excess trehalose to glycogen (cf. Fig. 3). 
Woodruff et al. (2004) constructed a mutant strain of M. smegmatis lacking all three 
trehalose biosynthesis pathways. They demonstrated that even though trehalose is vital 
for growth, the three pathways are functionally redundant, and possibly can substitute 
one another. 
Murphy et al. (2005) introduced mutations into each of the three trehalose biosynthesis 
pathways in M. tuberculosis and established a clear dominance of the Tps/Tpp pathway. 
The authors also concluded that TreYZ pathway is not essential for M. tuberculosis’ 
growth. A knock out mutant for Tpp2 (M. tuberculosis has two tpp genes) displayed a 
lethal phenotype and could not, conversely to other mutants defective for trehalose 
synthesis, be rescued by exogenous trehalose. Severe growth defects presented by the 
mutant demonstrate that trehalose phosphatase plays an essential role that cannot be 
accomplished by any other enzyme. The lack of phenotype for the Tps1 knock out clone 
is consistent with both the previous remark and the observation made by the authors that 
the protein product of Tps1 may lack functional trehalose-6-phosphate phosphatase 
activity. The Tpp2 mutant accumulates T6P which can be detrimental to the organism 
(Paul et al., 2008). According to Murphy et al. (2005) the lethal phenotype indicates 
that T6P has in Mycobacterium a signaling role similar to the one it plays in yeast. 
Mutant strains lacking TreS exhibited impaired infection capability, in vivo, which 
could reflect a need for the interconversion of stored trehalose into maltose and then 
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into usable glucose, during persistent infection with M. tuberculosis (Murphy et al., 
2005). 
Tropis et al. (2005) constructed mutant strains of Corynebacterium glutamicum unable 
to synthesize trehalose due to the knock-out of the genes for all three pathways of 
trehalose biosynthesis. The inability of the mutants to synthesize trehalose, in addition 
to an increase in osmosensitivity, led the cells to exhibit a stronger aggregation in liquid 
culture. After centrifugation of the cultures, analysis of the supernatant of the triple 
mutant strain revealed that the protein concentration was roughly 7-fold higher than in 
the wild-type. This suggests that trehalose might have an important role in protein 
stabilization. 
The authors also concluded that in the absence of trehalose C. glutamicum was capable 
of synthesizing mycolates using other sugars, such as glucose, maltose or maltotriose, as 
acceptors. Thus, in principle, the only requirement for mycolate synthesis would be the 
presence of an α-glucosyl-containing sugar in the medium. Hence, contradicting the 
general conviction that trehalose plays an essential role as a mycolate acceptor and in 
the resulting production of TMM; the authors consider the role of trehalose not to be a 
prerequisite for cell wall linked mycolate synthesis.  
3. Maltose and Maltose-1-phosphate 
Disaccharides are popular carbon sources which can be consumed, generally after 
breakdown to monosaccharides, followed by ATP dependent phosphorylation and 
subsequent incorporation into the central catabolic pathways. In bacterial sugar 
metabolism, the ATP-dependent phosphorylation of disaccharides does not seem to play 
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a significant role, it seems however to be widespread during transport (Postma et al., 
1993; Deutcher et al., 2006). 
Phosphorylation of disaccharides in the cytoplasm prior to degradation is a rare 
phenomenon which was identified in Aerobacter aerogenes in 1972 (Palmer & 
Anderson, 1972 a). This organism phosphorylates cellobiose in position 6 with 
consumption of ATP prior to hydrolysis (Palmer& Anderson, 1972 b). Latter, in 1996, 
Drepper et al. identified an enzyme (Maltokinase) capable of catalyzing an ATP-
dependent phosphorylation of maltose to maltose-1-phosphate, in cell-free extract of 
Actinoplanes sp. 
It was also reported that E. coli seems to be able to produce maltose-1-phosphate 
(mal1P) (Decker et al,. 1999) via TreC in an ATP-independent manner. The authors 
speculated that the phosphorylated disaccharide might play a role as an inducer of the 
mal operon. 
Although the glgE gene and its homolog were considered essential for the growth of M. 
tuberculosis (Sassetti et al., 2003) and M. smegmatis, Kalscheuer et al. (2010) were able 
to generate null deletion mutations of the gene in M. smegmatis, in minimal medium. 
The authors observed intriguing modifications in the ΔglgE mutants. The mutants 
accumulated large amounts of mal1P and were sensitive to the disaccharide trehalose, 
which induced bacteriostasis correlating with mal1P hyperaccumulation. Second-site 
gene deletions in the treS and pep2 (mak) genes conferred trehalose resistance and 
suppressed mal1P accumulation, caused by glgE inactivation. Inactivation of treS or 
pep2 genes prevented mal1P formation altogether in the ΔglgE mutant. Substantial 
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levels of the radiolabeled maltose intermediate were detectable only in Δpep2 strains, 
indicating its fast turnover to mal1P by Pep2 (Mak). 
The glgB gene, which was demonstrated to be essential in M. tuberculosis H37Rv, 
clusters with glgE and encodes a branching enzyme that is required for introducing α-
1,6-linked branches into linear α-1,4-glucans , for example glycogen. The authors found 
glgB to be nonessential in M. smegmatis. The M. smegmatis ΔglgB mutant was likewise 
sensitive to trehalose and trehalose sensitivity in an M. smegmatis ΔglgB strain could 
again be suppressed by deletion of the treS gene. 
GlgE inactivation is lethal in M. tuberculosis and the authors were unsuccessful in 
deleting glgE in the wild-type, but the gene could readily be inactivated in the ΔtreS 
mutant, confirming both the essentiality of GlgE and the causality of mal1P toxicity, 
respectively. Likewise, treS inactivation allowed deletion of glgB, demonstrating that 
mal1P toxicity is also the probable cause of GlgB essentiality. 
Cytoplasmic mal1P accumulation in the M. smegmatis ΔglgE mutant suggested that the 
phosphorilated sugar might be the direct substrate of GlgE. Also the unveiling of the 
mal1P-dependent maltosyltransferase activity of GlgE, combined with the phenotypes 
of the M. smegmatis mutants, allowed the authors to conclude that GlgE is part of a 
pathway that converts trehalose into an α-1,6-branched α-1,4-glucans via four 
enzymatic steps mediated by TreS, Pep2 (Mak), GlgE and GlgB. GlgE not only forms 
the linear α-1,4-glucan but it can also edit the branch lengths of branched glucan (cf. 
Fig. 3). 
The authors found that mal1P accumulation, as a result of GlgE inactivation, appeared 
to elicit pleiotropic stress responses in M. tuberculosis, including inhibition of 
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respiration and induction of the stringent response as well as DNA damage (Kalscheuer 
et al., 2010). In the authors opinion the mal1P-induced lethality might share certain 
aspects of the common mechanism of cellular death caused by bactericidal antibiotics in 
E. coli. However the authors do not exclude the hypothesis that mal1P might not be 
directly toxic to the cells but could rather lead indirectly to toxicity by more complex 
mechanisms. 
 
Figure 3 – Summary representation of the pathways related to maltose-1-
phosphate. Adapted from Elbein et al. (2003); Tropis et al. (2005); Pan et al. 
(2004); Pan et al. (2008); Elbein et al. (2010) and Kalscheuer et al. (2010) 
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In the early 90’s it was discovered that, in yeast, the trehalose synthase small subunit, 
(TSS1), as well as synthesizing T6P, controlled glucose influx into glycolysis. One of 
the hypotheses proposed to explain the phenomenon is that T6P can restrict sugar flux 
by inhibiting hexokinase activity (Paul et al., 2008). 
In the nematode Caenorhabditis elegans, mutation of a TPP gene, gob-1 (gut obstruct), 
is lethal. The mutation is thought to be lethal owing to the toxic buildup of T6P, 
suggesting that controlled levels of T6P are required for metabolic regulation (Kormish 
& McGhee, 2005). 
In plants, there is a strong correlation between T6P and sucrose content. In addition to 
regulating the utilization of sucrose the amounts of T6P also respond strongly to this 
sugar. The amount of T6P is inversely related to the amounts of hexose phosphates and 
UDP-glucose suggesting that T6P may regulate the amounts of these intermediates 
(Paul et al., 2008). Sucrose would have in T6P a dynamic, specific and rapid signal. 
T6P would provide a further level of communication that could integrate information on 
sucrose supply with other factors, such as environmental stress (trehalose pathway 
genes are strongly regulated by stress as well as by sugar). Furthermore, as it is not part 
of a major metabolite flux toward an important end-product, T6P levels can fluctuate 
without compromising other functions, as would happen for central metabolites such as 
glucose-6P and UDP-glucose, from which T6P is synthesized. Potentially T6P could 
also signal the availability of these central intermediates (Paul, 2008). 
Some authors propose a signaling role for mal1P similar to that of T6P. (Decker et al., 
1999) 
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3.1. Maltokinase 
As formerly stated Drepper et al. identified a maltokinase (Mak) in 1996, in cell-free 
extract of Actinoplanes sp. The enzyme was isolated from crude extracts of 
Actinoplanes missouriensis and characterized only in 2003 by Niehues et al. 
The enzyme maltokinase can catalyze the ATP-dependent phosphorylation of maltose to 
maltose-1-phosphate (mal1P). This reaction product was identified in 1967, by Narumi 
and Tsumita, in extract of Mycobacterium bovis BCG. 
The gene coding for Mak, Rv0127 in M. tuberculosis and MMar_0326 in M. marinum, 
is identified in several genomic databases such as the Kyoto Encyclopedia of Genes and 
Genomes (KEGG, http://www.genome.jp/kegg/) or Institut Pasteur 
(http://genolist.pasteur.fr/TubercuList/). 
The mak gene is located adjoining the treS gene, the gene coding for the enzyme 
catalyzing the interconversion of maltose to trehalose, which suggests the inclusion of 
both genes in the same transcriptional unit and the involvement of the two enzymes in 
the same metabolic pathway. Several other organisms present the same genetic 
conFiguration and in others, like M. smegmatis (MSMEG_6514), the genes are even 
fused together into one bifunctional treS/mak gene, which reinforces the previous 
consideration (Mendes et al., 2010). 
The mak gene was considered essential for M. tuberculosis growth (Sassetti et al., 
2003), implying a capital function in bacterial metabolism. In A. missouriensis Mak 
seems to be expressed constitutively, independently of the growth phase and of the 
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sugars present in the growth medium (Niehues et al., 2003). This points to a possible 
function in anabolism, or to a role of mal1P as an effector molecule. 
Niehues et al. (2003) characterized the Mak as a monomeric enzyme, with an estimated 
molecular mass of 57 kDa. The enzyme followed Michaelis-Menten kinetics, with a Km 
of 2.6 mM for maltose and 0.54 mM for ATP. Apparently the enzyme had a higher 
affinity for the phosphoryl-group donor than for the sugar substrate. Maltokinase 
exhibited a high specificity for maltose, relatively to similar disaccharides. The 
specificity for ATP as the phosphoryl-group donor was high (CTP, GTP, TTP, and 
UTP, showed little or none significant activity). The pH optimum was between 7 and 9. 
The authors observed that the Mak activity was independent from the physiological 
state (exponential/stationary phase) of the bacteria or the maltose content of the broth. 
Even in a minimal medium with glucose, L-arabinose or D-xylose as a carbon source, 
Mak activity was present. 
Jarling et al. (2004), following Niehues et al. (2003) work, isolated Mak1 from 
Actinoplanes missouriensis and Pep2 (Mak) from Streptomyces coelicolor, located on a 
gene cluster similar to that of Mak1 in A. missouriensis. The authors partially 
characterized the enzymes, to confirm their identity, and concluded that their proprieties 
were similar to the enzyme previously characterized by Niehues et al. (2003). Although 
both proteins appeared to be distantly related to aminoglycoside phosphotransferases 
(APHs) neither Mak1 nor Pep2 did phosphorylate any of the tested aminoglycosides. 
Therefore the authors concluded that it is physiologically unlikely that Mak1 or Pep2 
could act as enzymes conferring aminoglycoside resistance to their hosts. 
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Mendes et al. (2010) characterized, for the first time, a mycobacterial Mak, in this case 
the enzyme from Mycobacterium bovis BCG, an enzyme with 99-100% amino acid 
identity to the Mak from M. tuberculosis strains. The protein was monomeric in 
solution, with a molecular mass of c. 50.7 ±4.2 kDa. The enzyme was dependent on 
maltose (Km 2.52±0.40 mM) and ATP (0.74±0.12 mM), although GTP and UTP could 
be used to produce mal1P and residual activity could also be detected with maltotriose, 
maltoetraose, maltopentaose and maltoheptaose as phosphate acceptors (maltose 
contamination could not be excluded).. Divalent cations were required for activity and 
Mg
2+
 was the best activator. The enzyme was active between 20 and 65°C, with 
maximal activity at about 60°C and at 37°C its pH range was between pH 6 and 11. 
Similarly to the enzymes from A. missouriensis and S. coelicolor, only maltose served 
as the acceptor substrate but, unlike those organisms’ proteins the M. bovis BCG 
maltokinase was able to use ATP, GTP and UTP with comparable efficiency. This 
substrate flexibility may reflect an absolute requirement for mal1P, corroborating the 
proposed essentiality of the mak gene in M. tuberculosis. 
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Objectives 
Maltokinases (Mak) are present in nearly all mycobacterial genomes available (Mendes 
et al., 2010). Moreover, the corresponding gene in Mycobacterium tuberculosis 
(Rv0127) has been considered essential for the growth of this organism (Sassetti et al., 
2003). However, only recently has a mycobacterial Mak been successfully expressed to 
allow functional characterization (Mendes et al., 2010), nonetheless the physiological 
role of this enzyme remains to be fully elucidated. Therefore, in an effort towards 
unveiling the role of Mak in mycobacterial physiology we decided to analyze the 
transcriptional responses of the corresponding gene in M. smegmatis, a suitable model 
mycobacterium, under different nutritional conditions. We also decided to explore 
additional functions of the enzyme in vitro, namely by testing possible alternative 
substrates (phosphoryl acceptors) as well as the possibility of the involvement of this 
enzyme in the inactivation of aminoglycoside antibiotics. Concurrently, to confirm the 
proposed essentiality of Mak in M. tuberculosis, we selected the closely related model 
organism M. marinum as the tool for the construction of a mak conditional knock-out 
mutant, and thus, evaluate the effects of silencing the gene on the mutant’s phenotype. 
This multifactorial approach provides the grounds to further our knowledge not only of 
this enzyme’s physiological role but also of its integration in the general mycobacterial 
metabolism. 
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1. Mak Purification 
1.1. Cloning 
The maltokinase (mak) gene from M. bovis BCG was previously amplified by PCR, 
cloned into the expression vector pET30a (Novagen) and expressed in E. coli by V. 
Mendes (PhD dissertation) and described in the detail in the following publication 
(Mendes V, Maranha A, Lamosa P, da Costa MS, Empadinhas N., (2010) BMC 
Biochem 11:21). 
1.2. Strain, Culture Conditions and Overexpression 
E. coli BL-21 strain containing the pET30a plasmid with the maltokinase gene was 
grown in a 5L fermentor, in LB-Lennox medium with kanamycin (30 μg/mL), with 
continuous aeration and stirred at 180 r.p.m. at 37°C, pH 7.0. The bacteria grew to mid-
exponential phase (OD610=0.8). IPTG was added to a final concentration of 0.5 mM, to 
induce gene expression, and temperature was reduced to 20°C. The cells were harvested 
18h after induction, by centrifugation (9000 × g, 10 min, 4°C). 
1.3. Purification of the Recombinant Protein 
The maltokinase purification protocol was performed based on Mendes et al., (2010). In 
an attempt to optimize the purification procedure, particularly to enhance the separation 
of the His-tagged Mak and simultaneously reduce the number of chromatographic steps, 
the pH of the sodium phosphate starter buffer containing 20 mM imidazole and 500 mM 
NaCl, required for the nickel affinity chromatography, was not adjusted to 7.4 as 
indicated by the column supplier (GE Healthcare), but maintained at pH 11.0. 
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E. coli cells carrying the His-tagged recombinant Mak from M. bovis BCG were 
suspended in 20 mM sodium phosphate buffer at pH 11.0 with 500 mM NaCl and 20 
mM imidazole. A protease inhibitor cocktail (Roche), 10 μg/mL DNAse I and 5 mM 
MgCl2 were added to the suspension. Cells were disrupted twice in a French-press cell 
followed by centrifugation (15000 × g, 4°C, 30 min) and the suspension was then 
filtered through 0.45 µm cellulose filter (WVR). The recombinant protein was purified 
in a prepacked Ni-Sepharose high-performance column (His-Prep FF 16/10) 
equilibrated with 20 mM sodium phosphate, pH 11.0, 500 mM NaCl, and 20 mM 
imidazole. Elution was carried out with 500 mM imidazole and the purity of the 
fractions was determined by SDS-PAGE. A TLC (Thin Layer Chromatography) was 
made to discriminate the purest active fractions. These were pooled, diluted ten times 
with 25 mM BTP at pH 7.4 and loaded into a Q-Sepharose fast-flow column (Hi-Load 
FF 16/10), equilibrated with 25 mM BTP at pH 7.4 with 50 mM NaCl, and eluted by a 
linear gradient of NaCl (0 to 500 mM). A TLC was once again prepared to locate the 
purest active fractions. Concurrently a SDS-PAGE was preformed and the purest active 
fractions were pooled, concentrated by ultracentrifugation in 30 kDa cutoff centricons 
(Amicon), equilibrated with 25 mM BTP at pH 7.4 with 200 mM NaCl, and loaded into 
a Superdex 200 fast-flow column equilibrated with the same buffer. After SDS-PAGE 
analysis the active purest fractions were concentrated and equilibrated with 50 mM BTP 
at pH 7.4 with 200 mM NaCl. 
1.4. Substrate Specificity 
Maltokinase activity had already been tested for maltose, maltotriose, maltotetraose, 
maltopentaose, maltoheptaose and trehalose by V. Mendes incorporated in his PhD 
thesis work. However further substrate specificity determination was assessed for the 
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disaccharides cellobiose, gentiobiose, leucrose, melibiose, palatinose, sucrose, turanose 
and β,β trehalose and for the trisaccharide raffinose. Since the Mak protein had high 
sequence identity (>40%) with putative aminoglycoside phosphotransferases, the 
aminoglycoside antibiotics gentamicin and kanamycin, were also tested as possible 
phosphate acceptors (all from Sigma-Aldrich). Maltose was utilized as a positive 
control in both tests. The reaction mixtures (50 μL) containing 0.5 μg of pure 
recombinant Mak, 3 mM of each sugar substrate or 5mM of the aminoglycoside 
antibiotics, 10 mM MgCl2 and 50 mM BTP at pH 8.0, were incubated at 37°C for 10 
min. When required negative controls were included where pure recombinant Mak was 
replaced by water. The reaction products were visualized by TLC using acetic acid/ethyl 
acetate/water/ammonia 25% (6:6:2:1, v/v) and propanol/ethyl acetate/water/ammonia 
25% (5:1:3:1, v/v) as independent solvent systems. 
2. Transcriptional Responses 
2.1. Strains and Culture Conditions 
Mycobacterium marinum (DSMZ 44344 (Deutsche Sammlung von Mikroorganismen 
und Zellkulturen)) and Mycobacterium smegmatis strain mc
2
155 (ATCC 700084 
(American Type Culture Collection)) were grown in Middlebrook 7H9 Broth 
complemented with 0.2% of Tween 80 (Sigma), at pH6.6. Five different nutritional 
conditions were employed. A 2.5 g/L D-glucose (Molekula), D-trehalose (Sigma), D-
maltose (Sigma), glycerol (Prolabo) or L-glutamate (Sigma) supplement was added to 
the medium after being filter sterilized through a 0.2 µm cellulose acetate filter (VWR). 
Glycerol was added and autoclaved directly with the medium. 
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Cultures were inoculated to an initial optical density OD610=0.05. For preparation of 
cell-free extracts the cells were grown in 1 L metal capped Erlenmeyers containing 250 
mL of culture medium, for RNA extraction purposes the cultures were grown in 300 mL 
metal capped Erlenmeyers containing 100 mL of medium, in a water bath shaker at 
160 r.p.m. M. smegmatis cultures were grown at 37ºC, while M. marinum cultures were 
grown at 30ºC. Growth curves were made for all the nutritional conditions tested so that 
cells could be harvested in the same growth phase (late exponential and stationary 
phase). 
2.2. Activity in Cell-Free Extracts  
M. smegmatis cells grown in different nutritional conditions were harvested 17h after 
inoculation, by centrifugation (8000 × g, 10 min, 4°C). Cells were suspended in 20 mM 
BTP buffer at pH 7.0 and were disrupted in a French-press cell, followed by 
centrifugation (14000 × g, 4°C, 30 min). The cell-free extracts were then dialyzed in 
20 mM BTP buffer at pH 7.0 to remove unwanted substances, namely metabolites that 
could be substrates for Mak. 
Determination of protein concentration of the cell-free extracts was done according to 
the Bradford method (Bradford, 1976). 
Cell free extract activity was determined spectrophotometrically (Jenway 6405 UV/Vis) 
by measuring the ADP produced upon maltose phosphorylation. The assays were 
performed at 37 ºC. 50 µL reaction mixtures containing 20 µg of cell-free extract, 
50 mM BTP pH 8.0, 10 mM MgCl2, 2 mM maltose and 2 mM ATP were stopped at 
different times (0, 3, 6, 9 min) by cooling on ice . The protein was inactivated by the 
addition of 5 µL of 1N HCl and neutralized with 5 µL of 1N NaOH. The amount of 
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ADP released was determined by measuring the decrease in absorption at 340 nm, after 
incubation of the sample with 3 U of pyruvate kinase and lactate dehydrogenase, 
0.3 mM NADH and 2.0 mM phosphoenolpyruvate (all from Sigma-Aldrich), 2.5mM of 
MgCl2, 2.5mM of KCl and 50mM Tris HCl pH 7.4 to 1 ml mixture (total volume) for 
10 min at 30°C. 
2.3. Total RNA Isolation 
All plasticware and glassware were treated before use to ensure that they were RNase-
free. Chloroform-resistant plasticware (eppendorfs) were washed with chloroform to 
inactivate RNases, rinsed with RNase-free water and finally with ethanol. Glassware 
was washed with 5% HCl and rinsed with RNase-free water. Afterwards all material 
was autoclavated. Electrophoresis tanks were cleaned with 0.5% SDS, thoroughly 
rinsed with RNase-free water, followed by ethanol and allowed to dry. Aquous 
solutions were treated with 0.1% diethyl pyrocarbonate (DEPC), incubated overnight at 
37°C and autoclaved for 15 min to remove any trace of DEPC. Water was filtered 
through a 0.22 µm cellulose filter (VWR) prior to DEPC addition. Glass beads (0.1 mm, 
BioSpec Products) were washed with 5% HCl, rinsed with RNase-free water and baked 
in an oven at 160°C for 2 hours. 
For cleaning work surfaces RNase Zap (Ambion) was used. Pipettets were cleaned with 
ethanol and filtered tips (DIAMOND® Filter Tips Gilson) were utilized to prevent 
aerosol-borne contamination. 
Total RNA isolation was performed in duplicates, during exponential and stationary 
phase. The optimal amount of starting material was determined in order to attain 
approximately the same cell concentration throughout the samples. After testing several 
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culture volumes, the most favorable was settled to be a volume of 6 mL of culture at 
OD610=0.8. Total RNA was isolated from M. smegmatis cells grown for fourteen hours. 
DO610 was measured and the amount of starting material was calculated.  Subsequent 
total RNA purification was carried out with RNeasy Protect Bacteria Mini Kit (Qiagen) 
according to manufacturer’s indications. Mechanical disruption was employed to 
prepare the bacterial cells lysates, a 2 mL Safe-Lock Eppendorf containing 1 mL of 
acid-washed glass beads and the sample was attached to a vortex for 2 minutes. After on 
column DNAse treatment the samples were tested by conventional PCR (95ºC, 3min 
followed by 45x (95ºC, 10 s; 55ºC, 10 s; 72ºC, 15 s) with additional 72 ºC, 15s) with 
RpoB primers, to rule out DNA contamination. RNA quality following isolation was 
checked by formaldehyde agarose gel electrophoresis (1.2%). Nucleic acid 
concentration and sample purity were measured using a NanoDrop 1000 (Thermo 
Scientific). 
When DNA contamination was detected after the RNA extraction protocol, total RNA 
was further digested with RNase free DNase I (Ambion), according to manufacturers’ 
instructions. The nucleic acids solution was diluted to 10 μg nucleic acid/50 μL. The 
DNase was heat-inactivated at 65ºC for 10 min and beforehand EDTA had been added 
to the mixture at a final concentration of 5 mM. 
Successful elimination of DNA contamination was confirmed by conventional PCR, 
with RpoB primers, (3 min, 95ºC and 45x (10 s 95ºC, 10 s 55ºC, 15 s 72ºC) plus 15 s 
72ºC) (EDTA concentration was taken into account). RNA integrity subsequent to the 
digestion was checked by formaldehyde agarose gel electrophoresis (1.2%). sample 
purity and nucleic acid concentration were determined using a NanoDrop 1000 (Thermo 
Scientific). 
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cDNA was generated using Superscript III reverse transcriptase (Invitrogen) with 
random hexamers primers, according to the manufacturer’s instructions. 
2.4. Experimental Design and Testing of Specific Amplification Conditions 
Primers were designed using NCBI´s primer-BLAST 
(http://www.ncbi.nlm.nih.gov/tools/primer-blast/) with the default parameters except for 
melting temperature range (minimum 50ºC, maximum 60ºC, optimal 55ºC), PCR 
product size (minimum 150, maximum 200), organism (M. smegmatis or M. marinum) 
and database (genome (chromosomes form all organisms)). 
The rpoB gene (the gene encoding the β subunit of RNA polymerase) was chosen as an 
endogenous control as the ideal internal standard should be expressed at a constant level 
at all stages of development and should be unaffected by the experimental treatment. In 
addition, an endogenous control should also be expressed at roughly the same level as 
the RNA under study (Bustin, 2000). However extensive evidence suggests that all 
genes are regulated under some conditions and there is no universal reference gene with 
a constant expression so any system relying on reference genes should be carefully 
validated (Kubista et al., 2006). 
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Table I – Oligonucleotides sequences utilized for RT-PCR 
Target Primer name Forward primer [5’-3’] Reverse primer [5’-3’] Amplicon size 
rpoB RpoB TGTTCGTCACGGCTGAGTTC CGGTGGACTTGTCGATGGTC 189 
rpoB RpoB2 GTTTCATTTGCCAAGCTCCG GACATCGAGCCCGAGAAATC 197 
rpoB RpoB3 TTCATTTGCCAAGCTCCGTG ACATCGAGCCCGAGAAATCC 194 
mak Mak CCAGCGATTGGTGGATCAGG CCGCCTTGTCCAGTTCGTAG 179 
mak Mak2 CCGATGAGCGTTACCAGGTG TCGTCGATCAGCGACAACAG 154 
mak Mak3 TATCACAAGCTCGCGGACAC GCGTACTCGAACGACCTCAG 197 
treS TreS GAACCACACCTCCGATCAGC CGAACGTCCAGTTCGACTCC 155 
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Optimal primer concentration, annealing temperature and primer specificity were 
ascertained foremost by conventional PCR and agarose gel electrophoreses (1%, 
4v/cm). Amplification was obtained for rpoB with 800 nM, 80 nM and 8 nM, final 
primer concentrations, displaying stronger bands for higher primer concentration. 
Real-time PCR assays were performed to reassess optimal primer concentration, 
annealing temperature, primer specificity and cycle number. Optimal annealing 
temperature was considered to be 55ºC for all primers. Final primer concentrations of 
800 nM, 200 nM and 80 nM were utilized. Following quantification and melting curve 
analysis the ideal primer concentration was deemed to be 800 nM for all genes.  
2.5. Real-Time PCR Assay 
Real-time-PCR was performed in a LightCycler® Carousel-Based System (Roche 
Applied Science) and in a MiniOpticon Real-Time PCR Detection System (BioRad) 
utilizing the light cycler FastStart DNA Masterplus SYBR Green I (Roche). The RT-
PCR was done according to manufacturer’s instructions. The program employed 
consisted of 3min at 95ºC, followed by 45 cyles of 10 s at 95ºC, 10 s at 55ºC and 10 s 
(unless when specified) at 72ºC, additional 15 s at 72 ºC and melting curve analysis. 
The reaction mix contained 2 µL of each primer (10x concentrated), 4 µL of master mix 
(5x concentrated), 100 ng of cDNA (unless specified otherwise) and PCR-grade water 
to a final volume of 20 µL. Negative controls containing water instead of cDNA were 
included in each run to detect any DNA contamination. 
A Validation Experiment to determine if the ΔΔC
T 
calculation was suitable was 
optimized with cDNA input spanning from 100 ng to 5 ng. 
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3. Tetracycline-Controlled Conditional Mutants 
The construction design of the conditional mutant was carried out by V. Mendes (PhD 
dissertation). 
3.1. Strain, Culture Conditions and Plasmids 
E. coli DH5α, when necessary, were grown in LB-Lennox medium with gentamycin (15 
mg/mL) (in order to select transformants with a plasmid carrying a marker for 
gentamycin resistance). Cells were grown in test tubes containing 5 mL of medium, in a 
water bath shaker at 160 r.p.m. at 37ºC. For solid medium 2% agar was added. 
The pJQ200sk plasmid (cloning vector carrying a marker for gentamycin resistance) 
was used to construct the conditional mutant. pGEM®-T Easy (Promega) cloning vector 
or pUC57 (GeneScript) cloning vector were utilized to lodge the fragments necessary to 
the construction on the intermediary stages. The plasmid pTC-28S150x was the source 
of the kan cassette (KanR2) and the strong mycobacterial promoter Psmyc was 
amplified from the same promoter. PmyctetO, the TetR responsive element which 
confers tetracycline-inducible expression when tetR is co-expressed, was amplified 
from pTC0x1L plasmid (all from Addgene). 
3.2. DNA Manipulations 
The fragments KanR2, PmycTetO and Psmyc were amplified by PCR from the afore 
mentioned plasmids with a Taq DNA Polymerase (Invitrogen), according to 
manufacturer’s instructions. PCR amplification was verified by agarose gel 
electrophoreses (1%, 4v/cm). The products were then recovered from the agarose gel 
with the JETQUICK Gel Extraction Spin Kit (Genomed) and cloned into DH5α in a 
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pGEM®-T Easy cloning vector (Promega), allowing blue/white screening. After 
plasmid extraction, from white clones, with GenElute™ Plasmid Miniprep Kit (Sigma 
Aldrich), restriction analyses was performed with PstI/BamHI and sequencing 
(AGOWA) was carried out with M13F and M13R primers. The remaining two 
fragments (MakF and TreSF) were synthesized by GenScript and supplied in the pUC57 
cloning vector. The inserts were subsequently cloned into E. coli DH5α. After plasmid 
purification, as described above, and restriction with suitable enzymes (all from Takara) 
both to confirm the presence of the inserts and to be utilized in downstream procedures 
(cf. Table II), the fragments were recovered from the 1% agarose gel with the 
JETQUICK Gel Extraction Spin Kit (Genomed). 
To allow insertion of DNA the pJQ200sk plasmid was linearized with XhoI/ApaI. The 
first fragment to be cloned into the plasmid (MakF) had been previously digested with 
the same restriction enzymes. The plasmid and fragment were linked together by a T4 
DNA ligase (Promega) and cloned into E. coli DH5α host cells. Correct fragment 
insertion was confirmed by restriction analysis. For downstream applications the 
plasmid was digested with NdeI/PstI (Table II). The fragment was recovered from the 
agarose gel with the JETQUICK Gel Extraction Spin Kit (Genomed). The procedure 
was repeated for all the fragments, in sequential order, varying only in the restriction 
enzymes utilized. 
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Table II – restriction enzymes utilized for construction 
Fragment 
Restriction 
enzymes 
pJQ200sk XhoI/ApaI 
MakF+pJQ200sk PstI/NdeI 
MakF+pJQ200sk+PmycTetO BamHI/PstI 
MakF+PmycTetO+pJQ200sk+ 
KanR2 
BamHI/XbaI 
MakF+PmycTetO+ KanR2+ 
pJQ200sk+ Psmyc 
NotI/XbaI 
MakF+PmycTetO+ KanR2+ 
Psmyc+pJQ200sk+ TreSF 
- 
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Figure 4 - Schematic overview of the expected knock-out mutant 
construction. Represented by the orange full hemicircle the vector´s MCS 
(multiple cloning site), the blue segments represent the ORI (Origin of 
Replication) and gtmR (gentamicin resistance gene) Integration of the TetR-
responsive promoter PmyctetO, mycobacterial strong promoter Psmyc and 
kanamycin resistance cassette KanR2, via homologous recombination (black 
dotted lines). (A): M. marinum’s genome before homologous recombination 
(B): Expected result after homologous recombination 
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Chapter III      Results and Discussion 
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1. Mak Purification 
1.1. Purification of the Recombinant Protein 
The most critical step in the study of any protein or enzyme is its purification. The 
development of techniques for protein purification has been pivotal for many advances 
in biotechnology. The basis of all protein purification is separation; cell-free extracts of 
biomaterial are complex mixtures of the protein of interest along with contaminating 
proteins and some small cellular debris. Separation is based on the protein’s properties 
such as size, charge and the ability to bind, or be bound by, other molecules. The 
expression and purification of recombinant proteins facilitates characterization of 
proteins although often more than one purification step is necessary to reach the desired 
purity. The recombinant Mak protein was purified as described above in the Methods 
section. To achieve a better separation, and because the protein of interest had a broad 
pH range (pH 7 to 11, Mendes et al. (2010)), the sodium phosphate buffer was utilized 
at pH 11.0. The pH alteration allowed elution of purer fractions, narrowing down 
protein quantity for subsequent loads, which led to the purification of pure recombinant 
protein (Fig. 6) with the use of fewer columns. In fact the purity of the His-tagged 
recombinant Mak was high enough for biochemical characterization readily after the 
nickel-affinity column. The additional steps were performed to obtain a highly pure 
fraction for crystallography purposes and three-dimensional structure determination. 
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(A) 
 
(B) 
 
(C) 
 
Figure 5 - FPLC chromatograms of the His-tagged Mak purification from 
cell-free extracts. (A): Column: Ni-Sepharose high-performance (His-Prep 
FF 16/10). Fractions 2, 3 and 4 were pooled diluted ten times with 25 mM 
BTP at pH 7.4 and loaded into the following column (B): Column: Q-
Sepharose fast-flow column (Hi-Load FF 16/10). Fractions 2, 3, 4 and 5 
were pooled (C): Column: Superdex 200 fastflow column. Fractions 3 to 8 
were pooled concentrated and equilibrated with 50 mM BTP at pH 7.4 with 
50 mM NaCl 
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Figure 6 - SDS-PAGE (coomassie blue staining) of the fractions eluded from 
Superdex 200 fast-flow column following concentration by 
ultracentrifugation in 30 kDa cutoff centricons. Lane 1: molecular weight 
marker; lane 2: purified His-tagged Mak (50kD) 
1.2. Substrate Specificity 
In any organism phosphorylation does not happen spontaneously by mixing a substrate 
with ATP in aqueous solution. The coupling of an energy yielding reaction with an 
energy consuming one is catalyzed by enzymes. Enzymes also provide substrate 
specificity. Kinases are a ubiquitous group of enzymes central to many biochemical 
processes. The transfer of the terminal phosphoryl group to one substrate is a 
fundamental process in many aspects of metabolism, gene regulation and signal 
transduction. 
Maltokinase activity had already been tested for maltose, maltotriose, maltotetraose, 
maltopentaose, maltoheptaose and trehalose (by V. Mendes PhD thesis work and 
(Mendes et al., 2010)). 
In this work among the disaccharides and trissacharide substrates tested as possible 
phosphate acceptors no activity was detected, except for maltose, the positive control 
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(Fig. 7) which agrees with Niehues et al. (2003) and Jarlin et al. (2004) conclusions that 
the Actinoplanes missouriensis’ Streptomyces coelicolor’ Mak also exhibit a high 
specificity for maltose. 
Aminoglycoside antibiotics are a large family of antibiotics that kill bacteria by binding 
to the bacterial ribosome and reducing fidelity of protein synthesis or inhibiting protein 
synthesis. The major mechanism of aminoglycoside resistance is enzymatic 
modification. Aminoglycoside phosphotransferases (APHs) perform cofactor-dependent 
drug modification in the bacterial cytoplasm; modified aminoglycosides bind poorly to 
the ribosome allowing bacteria to survive in the presence of the drug (Valulenko & 
Mobashery, 2003). Due to the sequence similarities of Mak with putative 
aminoglycoside phosphotransferases (>40%), the aminoglycoside antibiotics gentamicin 
and kanamycin were also tested as possible acceptors of phosphate but no activity was 
detected (Fig. 8). This is in accordance with the authors Jarling et al. (2004) findings for 
Actinoplanes missouriensis and Streptomyces coelicolor Mak proteins. 
In M. smegmatis maltose appears to be highly specific as an acceptor of the phosphate 
group.
  Results and Discussion 
53 
 
 
Figure 7 – Reaction products of the disaccharides and trisaccharide 
substrates tested as possible phosphate acceptors for Mak, visualized by 
TLC. Acetic acid/ethyl acetate/water/ammonia 25% (6:6:2:1, v/v) used as a 
solvent system. From left to right mal1P, maltose, ATP, ADP, cellobiose, 
gentiobiose, leucrose, melibiose, palatinose, sucrose, turanose, β,β trehalose 
and raffinose utilized as references, followed by a negative control (for the 
maltose reaction), the maltose reaction and the disaccharides and 
trisaccharide reaction, in sequential order (as previously described in the 
Methods) 
 
Figure 8 – Reaction products of the aminoglycoside antibiotics gentamicin, 
and kanamycin tested as possible phosphate acceptors visualized by TLC, 
utilizing propanol/ethyl acetate/water/ammonia 25% (5:1:3:1, v/v) as a 
solvent system. From left to right ATP, ADP, glucose, kanamycin and 
gentamicin, applied as references, followed by the kanamycin and 
gentamicin reactions and corresponding negative controls (as previously 
described in the Methods) 
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2. Transcriptional Responses 
2.1. Influence of Carbon and Nitrogen Sources on Growth 
Bacterial requirements for growth include sources of energy, organic carbon (e.g. 
sugars). Some carbon sources are utilized preferentially to others, favored sugars such 
as glucose, as long as they are present in sufficient amounts in the growth medium, 
repress the synthesis of the enzymes necessary for the transport and metabolism of less 
favorable carbon sources. This phenomenon became known as carbon catabolite 
repression (CCR). Deutscher et al. (2006) define CCR more broadly, as the inhibitory 
effect a certain carbon source has on gene expression and/or the activity of enzymes 
involved in the catabolism of other carbon sources. 
Metabolic control at the enzymatic level is a function not only of the enzyme 
concentration, and thereby gene expression, but also of the interaction between enzymes 
and metabolites. Substrate availability (concentration) depends on active membrane 
transport systems (pumps, transporters) and the passive diffusion via substrate specific 
membrane proteins (ion channels, facilitators). Within a pathway there is a very tight 
control of fluxes such that the rates of synthesis and conversion of metabolites are kept 
in close balance over a very wide range of external conditions. 
Owing to the complexity of metabolic networks, it is not obvious which reactions are 
essential and which are not, therefore, eliminating reactions overflow by growing 
organisms in sole carbon sources can be enlightening. 
Despite the clear advantage of structuring biochemical reactions into pathways, it tends 
to leave the impression that these pathways are separate units that serve specific 
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purposes in the cell. This is by no means the situation and, the different pathways are 
often interconnected, resulting in a complex network of biochemical reactions. 
As shown in Fig. 9A Mycobacterium smegmatis grows very well on glucose and 
glycerol, grows acceptably in trehalose and glutamate but grows poorly in maltose. 
Likewise M. marinum grows poorly on maltose but unlike M. smegmatis its favorite 
energy source is glutamate, followed by glucose, glycerol and trehalose (Fig. 9B). 
These nutritional preferences diverge from the ones observed by Wolf et al. (2003) and 
Tropis et al. (2005) in Corynebacterium glutamicum. The authors observed that the 
wild-type bacterium could not grow on trehalose but was perfectly capable of growing 
on maltose. However the authors Titgemeyer et al. (2007) detected poor growth on 
maltose as a sole carbon source in M. smegmatis, this being also true for M. tuberculosis 
(Edson, 1951). Pan et al. (2008) observe that, until now, it has not been clear where 
mycobacteria could obtain the maltose to transform into trehalose because M. 
smegmatis grows very poorly on maltose. This poses the conclusion that the metabolism 
involving these sugars must be particular to mycobacteria. 
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Figure 9 – Plot representing the growth of (A): Mycobacterium smegmatis 
(B): Mycobacterium marinum in 7H9 medium with glucose, thehalose, 
maltose, glycerol or glutamate as a carbon source 
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2.2. Activity in Cell-Free Extracts 
The activity of maltokinase was measured as the rate of maltose-dependent formation of 
ADP from ATP. The ADP production was coupled to oxidation of NADH (β-
nicotinamide adenine dinucleotide) by adding phosphoenolpyruvate (PEP) and purified 
pyruvate kinase and lactate dehydrogenase (cf. Fig. 10). The assay was performed in the 
presence of an excess of these reagents. Under these conditions, formation of ADP 
resulted in the oxidation of an equimolar concentration of NADH. A unit is defined as 
the amount of enzyme that catalyzes the removal of 1 µmole of substrate per min under 
standard assay conditions (Orston & Orston, 1969). 
 
Figure 10 – Outline of the coupled reactions where ADP can be quantified 
by a loss of NADH 
As shown in Fig. 11 there are no significant differences in the Mak activity among the 
carbon sources utilized, with the exception of maltose. The activity of the protein Mak 
in maltose was 1.52 times lower than in glutamate.  
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Figure 11- Specific activity of maltokinase in Mycobacterium smegmatis 
cell-free extracts grown in glutamate, glucose, glycerol, maltose and 
trehalose 
The low enzyme activity on maltose coupled with the fact that M. smegmatis grows 
poorly on maltose might indicate the lack of uptake of this sugar, although M. 
smegmatis has several homologues for maltose transporters and this sugar was 
suggested to be transported by the permease ABC
Sug
. The similarities of the ABC 
systems (ATP-binding cassette (ABC) transporter family) to known transporters outside 
the genus Mycobacterium is so low (<25 %) that substrates of these transporters cannot 
be predicted (Titgemeyer et al., 2007). Glycerol is used as the standard carbon source to 
grow M. tuberculosis; however, no specific uptake system is known, or apparent, by 
sequence similarity (Titgemeyer et al., 2007). Since M. tuberculosis grows with a 
generation time of 24 h and it has been shown that glycerol can directly diffuse through 
lipid membranes, it is conceivable that the rate of glycerol intake by passive diffusion 
may be sufficient for growth. Incoming glycerol would then be converted by glycerol 
kinase (GlpK) to glycerol-3-phosphate (G3P), which could then be converted by 
dehydrogenation to dihydroxyacetone phosphate (DHAP) by the enzyme glycerol-3-
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phosphate dehydrogenase. DHAP can then be rearranged into glyceraldehyde 3-
phosphate (GA3P) by triose phosphate isomerase (TIM), and feed into glycolysis (cf. 
Fig. 12). 
Glutamate has a long history of being a preferred substrate of mycobacteria. In 1951 
Edson reviews an increase in the measured the oxygen consumption in the presence of 
glutamate and reports this amino acid as one of the few nitrogenous substances that the 
bacteria is capable of oxidize. In 1963 Lyon et al. described some of the proprieties of 
the glutamate uptake system and concluded that a specific transport system for this 
amino acid should exist. Once glutamate has entered the cell via diffusion across the 
cytoplasmic membrane, or by protein-dependent transport, it is assimilated thanks to the 
glutamate dehydrogenase (GDH) that converts it to α-ketoglutarate, which can enter 
central metabolism via the Krebs cycle (cf. Fig. 12). 
From the work of Woodruff et al. (2004) that disabled key-enzymes required for each of 
the three trehalose synthesis pathways in M. smegmatis resulting in a mutant unable to 
proliferate unless supplemented with trehalose, it can be concluded that an uptake 
system of a sort must exist. Titgemeyer et al. (2007) also propose the existence of an 
uptake system exist for this sugar after growing M. smegmatis in trehalose as the sole 
carbon source. 
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Figure 12– Integration of the metabolic pathways of the carbon and nitrogen 
sources utilized leading to maltose-1-phosphate production 
 
2.3. RNA Isolation 
Obtaining high quality, intact RNA is the first, and often the most critical, step in 
performing RT-PCR. Starting with low quality RNA may strongly compromise the 
results of downstream applications. Obtaining high quality RNA is determinant to the 
reproducibility and biological relevance of subsequent procedures. 
To ensure reliable gene expression analysis RNA should ideally be stabilized in vivo. 
Bacterial mRNAs usually have a very short half-life, often only a few minutes and 
genes may be induced during handling and processing of bacterial cells, leading to 
higher expression of specific genes. 
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Many cellular decisions are reflected in altered patterns of gene expression. The ability 
to quantitate transcription levels of specific genes is central to any research into gene 
function. RT-PCR is the most sensitive and flexible quantification method and it can be 
used to compare the levels of mRNAs in different sample populations, to characterize 
patterns of mRNA expression, or to discriminate between closely related mRNAs. 
Nevertheless, its successful application depends on careful experimental design and 
validation remains essential for accurate quantitative measurements of transcription 
(Bustin, 2000; Bustin & Nolan, 2004). 
The optimal amount of starting material for total RNA extraction was determined in 
order to attain approximately the same cell concentration throughout the samples. After 
testing several culture volumes, the most favorable was settled to be a volume of 6 mL 
of culture at OD610=0.8. 
As shown in Fig. 13 agarose gel electrophoresis following PCR amplification of total 
RNA extraction revealed that most samples were contaminated with genomic DNA. 
RNA quality was checked by denaturing gel electrophoresis (formaldehyde agarose) the 
visualization of sharp 23S and 16S rRNA bands (as opposed to smeared bands) is a 
good indication that the RNA is intact (Fig. 14). 
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Figure 13 – PCR products examined via ethidium bromide-stained agarose 
gel electrophoresis (2%) following RNA extraction and DNase on column 
digestion (Bioron 1Kb DNA ladder). From the bottom left to the upper right. 
Samples extracted from M. smegmatis in exponential phase, grown in 
glucose, trehalose, maltose and glutamate (two replicates); samples extracted 
from M. smegmatis in stationary phase, grown in glucose, trehalose, maltose 
and glutamate (two replicates); samples extracted from M. marinum in 
exponential phase, grown in glucose, trehalose, maltose and glutamate 
 
Figure 14 – Denaturing formaldehyde agarose gel (1.2%) following total 
RNA isolation examined via ethidium bromide-staining. Samples extracted 
from M. smegmatis in exponential phase, grown in glutamate 
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As Fig. 15 demonstrates after treatment with DNase I genomic DNA contamination was 
successfully eliminated. Controls were run with EDTA to account for possible Taq 
polymerase inhibition (Fig. 15 B). EDTA was added to the control PCR reaction in 
same final concentration as in the reaction containing RNA. RNA quality was once 
again checked by denaturing gel electrophoresis in a formaldehyde agarose gel (Fig. 
17). The decrease in band intensity can be explained by some total RNA loss after 
digestion, as shown in Table III. 
Although the addition of EDTA to the digestion reaction tainted the RNA samples 
(A260/230 ratios Table III) it was strictly necessary so that the RNA would not undergo 
chemical scission when heated, since magnesium and other metals catalyze non-specific 
cleavages in RNA. A protocol consisting of chloroform: isoamyl alchol (24:1) 
extraction, followed by precipitation with absolute ethanol overnight at -80ºC and 
washing with 70% ethanol RNase-free, in order to eliminate the DNase and the EDTA, 
was attempted several times. However this extraction protocol implied significant RNA 
losses whilst the heat-inactivating alone sufficed to decontaminate the RNA and the 
EDTA created no problems for any downstream procedures. 
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Figure 15 - PCR products examined via ethidium bromide-stained agarose 
gel electrophoresis (2%) following DNaseI digestion (Bionron 1Kb DNA 
ladder). (A): From left to right. Sample extracted from M. smegmatis in 
stationary phase, grown in glucose, positive control run with cDNA. (B): 
From left to right. Sample extracted from M. smegmatis in stationary phase, 
grown in glutamate, positive control run with cDNA with 0.2 mM EDTA 
and without EDTA 
 
 
Figure 16 – Denaturing formaldehyde agarose gel (1.2%) following DNaseI 
digestion examined via ethidium bromide-staining. Sample extracted from 
M. smegmatis in stationary phase, grown in glutamate 
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Table III – RNA concentration and sample purity measured on a Nanodrop 1000, prior and after digestion with DNase I. Samples grown on Glutamate (Glut) 
and Glucose (Glu), RNA extracted in exponential or stationary phase (est) 
Sample Prior to diggestion After diggestion 
 RNA concentration 
(ng/µL) 
Sample purity 
(260/280 ratio) 
Sample purity 
(260/230 ratio) 
RNA concentration 
(ng/µL) 
Sample purity 
(260/280 ratio) 
Sample purity 
(260/230 ratio) 
Glut 89.7 2.13 0.34 - - - 
Glut2 363.6 1.90 1.86 - - - 
Glu est 2 262.9 2.10 1.84 74.1 2.06 1.49 
Glut est 2 400.6 1.92 2.01 151.4 1.88 1.31 
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2.4. Experimental Design and Testing of Specific Amplification Conditions 
Optimal primer concentration, annealing temperature and primer specificity were 
ascertained foremost by conventional PCR and agarose gel electrophoreses (2%, 
4v/cm). Amplification was obtained for rpoB with 800 nM, 80 nM and 8 nM, final 
primer concentrations, displaying stronger bands for higher primer concentration. The 
mak and treS amplicons were not visible after gel electrophoreses. Annealing 
temperatures ranging from 50 to 60ºC (50, 52, 55, 58 and 60ºC) were tested. No 
amplification was obtained for 50ºC. For 52 and 58ºC amplification held some 
unspecific products, while for 60ºC gel analysis showed a very weak band. Annealing 
temperature at 55ºC obtained optimal amplification. No conclusion could be drawn 
from conventional amplification and agarose gel electrophoreses (2%) in regard to the 
mak and treS amplicons for they were not visible after gel electrophoreses. 
Real-time PCR assays were performed to reassess optimal primer concentration, 
annealing temperature, primer specificity and cycle number. Optimal annealing 
temperature was considered to be 55ºC for all primers. Final primer concentrations 800 
nM, 200 nM and 80 nM were utilized (Fig. 17). Although primer concentration did not 
appear critical to RpoB amplification (Fig. 17 B) it had an extreme influence on TreS 
amplification (Fig. 17 D). Agarose gel analysis was congruent with melting curve 
analysis showing that primer concentration had a great impact on TreS amplification 
and primers concentration 200 nM and 80 nM were insufficient for optimal 
amplification. In regard to RpoB there was also a decrease in amplification although not 
so pronounced (Fig 18). Following quantification, melting curve analysis and agarose 
gel electrophoresis the ideal primer concentration was deemed to be 800 nM for all 
genes (Fig. 18). 
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For the mak and rpoB amplicons six primers were tested but only Mak3 and RpoB2 
were target specific and did not originate primer dimers. Mak amplified a non specific 
product with c. 400 bp (Fig. 18 in blue) and Mak2 was prone to dimer formation. RpoB 
was liable to mispriming and both RpoB and RpoB3 originated primer dimers (although 
RpoB3 in inconsequential amounts) (Fig. 20-88ºC peak and Fig. 21 signaled in a black 
dotted line). RpoB negative control shows amplification product not only due to primer 
dimer formation but also to DNA contamination (Fig 19 blue line). However, the 
difference in C(t) (threshold cycle - cycle at which the fluorescence crosses the 
threshold (level of detection of fluorescent intensity above background)) (Table V) for 
the various amplicons in Fig. 20 can be explained due to primer dimer formation in the 
control reaction. Despite having no amplicon amplification on the negative controls 
(Fig. 20 TreS amplicon peak at 90.5ºC vs. negative control dimer peak at 80.5ºC or 
Mak3 amplicon peak at 92.5ºC vs. negative control dimer peak at 84ºC) primer dimer 
prevents the absence of amplification. Mispriming can also be problematic (Fig 20 
RpoB peak 88ºC), once again preventing the occurrence of negative controls (for a 
better understanding of the amplification plots cf. Fig. 19 to 21 with Tables IV to VI). 
Primer dimer formation can be challenging when trying to obtain a negative control 
because SYBR Green dye will bind to any double stranded DNA molecule, as such any 
primer dimers will cause higher background and may lead to amplification on the 
negative controls. The presence of primer dimers can be easily identified by the 
presence of additional peak or peaks in the melting curve analysis. The primer dimer 
peaks usually appear at low melting temperatures. Mispriming can also be a problem 
because it will leave less primer available for annealing to the target sequence and 
amplification of a non specific sequence will present erroneous C(t) values. 
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At this point annealing time was lowered from 15 seconds to 10 seconds in order to 
prevent the amplification of non specific products. 45 cycles, as recommended by the 
FastStart DNA Masterplus SYBR Green I (Roche) manufacturers’, was considered ideal 
to cover low starting concentration of template DNA. 
 
 
Figure 17 - Quantification analysis of RT-PCR products from a SYBR Green 
I assay. (A): Amplification curve for all samples (B): Melting curve analysis 
for RpoB primer concentration 800 nM, 200 nM and 80 nM (C): Melting 
curve analysis for Mak primer concentration 800 nM, 200 nM and 80 nM 
(D): Melting curve analysis for TreS primer concentration 800 nM, 200 nM 
and 80 nM 
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Figure 18 - RT-PCR products examined via ethidium bromide-stained 
agarose gel electrophoresis (2%) (Bioron 100 bp + 1.5 kb DNA Ladder). 
From the upper left to the bottom right (reactions in triplicates) RpoB 
primers final concentrations 800 nM, 200 nM and 80 nM, Mak primers, TreS 
primers, negative controls (as previously described in the Methods). 
Signaled in blue Mak non specific product with c. 400 bp. Signaled in red 
primer dimer formation by the Mak primer 
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Figure 19 - Quantification analysis of RT-PCR products from a SYBR Green 
I assay. (A): Amplification Curve; relative florescence units plotted as a 
function of cycle number. Black line representing the threshold line (B): 
Melting analysis; the negative first derivative of the change in fluorescence 
plotted as a function of temperature 
 
Table IV – Table showing the C(t) of RT-PCR products from a SYBR Green I assay  
Sample C(t) 
RpoB 21.33 
Mak3 25.46 
TreS 21.27 
Ct- RpoB 34.77 
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Figure 20 - Quantification analysis of RT-PCR products from a SYBR Green 
I assay. (A): Amplification Curve; relative florescence units plotted as a 
function of cycle number. Black line representing the threshold line (B): 
Melting analysis; the negative first derivative of the change in fluorescence 
plotted as a function of temperature 
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Table V – Table showing the C(t) of RT-PCR products from a SYBR Green I assay  
Sample C(t) 
RpoB 20.93 
Ct- RpoB 32.23 
Mak 24.09 
Ct- Mak 37.83 
TreS 21.42 
Ct- TreS 42.49 
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Figure 21 - Quantification analysis of RT-PCR products from a SYBR Green 
I assay. (A): Amplification Curve; relative florescence units plotted as a 
function of cycle number. Black line representing the threshold line (B): 
Melting analysis; the negative first derivative of the change in fluorescence 
plotted as a function of temperature 
 
Table VI - showing the C(t) of RT-PCR products from a SYBR Green I assay  
Sample C(t) 
RpoB2 23.07 
RpoB2 Ct- - 
RpoB3 23.05 
RpoB3 Ct- 43.87 
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2.5. Real-Time PCR Assay 
When the validation of the ΔΔC
T
 experiment was started a series of technical problems 
were encountered. Contaminations, primer dimer formation and mispriming were 
common problems when trying to conduct an experiment. Several controls were 
inserted to try and locate the source of the contamination but no conclusion was drawn 
except that aerosol-borne contamination made reagent viability very short. To account 
for dimer formation more than one primer was used in an experiment but again no 
conclusion could be reached. 
3. Tetracycline-Controlled Conditional Mutants 
3.1. DNA Manipulations 
Reverse genetic techniques are essential tools for studying genes vital for growth. The 
ability to express gene products in a temporally restricted manner has been an essential 
experimental strategy in determining gene function where mutant or knockout studies 
are not possible. A straightforward method for obtaining conditional mutants is to 
replace the native promoter of a target gene with a tightly regulated promoter whose 
activity can be controlled experimentally. 
Tet repressor (TetR) proteins regulate the expression of a family of tetracycline (Tc) 
exporting proteins. The Ptet promoter expresses TetR. In the absence of Tc TetR binds 
the tet operator (tetO) in the tetA promoter and suppresses transcription of tetA, which 
encodes the Tc exporter. Once Tc enters the cell it binds TetR and induces a 
conformational change that results in dissociation of TetR from tetO and thus induces 
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expression of TetR controlled genes (cf. Fig. 22). Induction of TetR occurs prior to 
inhibition of the ribosome by tetracycline because affinity of TetR for these drugs is 10
3
 
to 10
5
 fold higher than the affinity of the drugs for the ribosome. Tetracyclines can cross 
biological membranes by diffusion, enabling these inducers to penetrate most bacterial 
cells. 
 
Figure 22 – Tetracycline regulated gene expression. (A): The Tet operon 
(B): The adaptation of the Tet operon to controlled transcriptional activation 
 
Bacteria synthesize restriction endonucleases to protect themselves from attack by 
viruses. These enzymes recognize particular base sequences, recognition sites, and 
cleave that DNA at defined positions. Each species of bacterium protects its own DNA 
by methylation at the recognition site, so that only invading viral DNA is cleaved and 
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degraded. Because of the sequence specificity, the positions of cuts within a DNA 
molecule can be predicted, assuming that the DNA sequence is known, enabling defined 
segments to be excised from a larger molecule. This ability underlies gene cloning and 
all other aspects of recombinant DNA technology. 
As previously described in methods the insertion of the various fragments into the 
pJQ200sk plasmid was sequential and before proceeding to next step. Correct fragment 
insertion was always confirmed by restriction analysis. Fig. 23 depicts an agarose gel 
electrophoresis of the restriction analysis of the last step of the construction. Lanes 2, 4 
and 5 are positive samples with bands displaying the expected molecular weights 
(~6400 and ~2400 bp). The sample in lane 3 is negative. The higher molecular weight 
bands in lanes 2, 4 and 5 are uncompleted digested plasmid DNA. This can be due to 
several situations namely contaminants left by minipreps that might partially inhibit the 
activity of the restriction endonuclease and supercoiled plasmid DNA, which is 
generally more difficult to digest than linear DNA excess of plasmid DNA, or even 
excess undigested plasmid DNA. 
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Figure 23 –Agarose gel electrophoresis 1% (ethidium bromide stain) 
following plasmid extraction and restriction analysis (NdeI) of four samples 
of the last step of the construction 
(MakF+PmyctetO+KanR2+Psmyc+TreSF). Lane 1: molecular weight 
marker (1Kb DNA ladder Bioron) Lanes 2, 4 and 5: positive samples (bands 
displaying 6400 and 2400 bp) Lane 3: negative sample 
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Chapter IV        Conclusion 
  
  Conclusion 
79 
 
In order to examine specific functions of the Maltokinase the protein had to be purified. 
Protein purification is based on the separation of the protein of interest of contaminant 
proteins. This can be a time-consuming process. The purification of the recombinant 
His-tagged Mak was made less laborious by the modification of the sodium phosphate 
buffer pH. Subsequently several substrates were tested as phosphoryl group acceptors. 
As multidrug resistant Mycobacterium strains pose a serious obstacle to the control of 
tuberculosis and atypical infections and given that the Mak had an high sequence 
homology to aminoglycoside phosphotransferases it was tested if the enzyme could 
confer aminoglycoside resistance by phosphorylating aminoglycosides antibiotics. 
Beyond the aminoglycoside antibiotics disaccharides and trisaccharides were also tested 
as phosphate acceptors however no activity was detected, except for maltose, 
implicating that in M. smegmatis the role of phosphate acceptor might be specific to 
maltose. It is then extremely unlikely that the protein could render aminoglycoside 
resistance to bacteria. 
RT-PCR is an exceptionally sensitive and useful quantification method and extremely 
adequate to analyze the transcriptional responses of the mak gene in different nutritional 
conditions, as proposed. Nevertheless, for accurate quantitation careful experimental 
design and validation are critical. The optimization of an RT-PCR experiment is time-
consuming but absolutely essential in order to obtain accurate reproducible results.  
Gene expression systems are valuable tools for the characterization of genes. The 
construction described here will consent the conditional expression of genes essential 
for mycobacterial growth and in doing so allow a better understanding of their 
involvement in mycobacterial metabolism. 
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In regard to the RT-PCR experiment and the conditional mutants the lack of time was 
the major issue, preventing us from reaching our intended objectives. However, if 
pursued, this broad spectrum approach can add to our knowledge of this enzyme’s 
physiological role, its response to diverse conditions and also of its integration in the 
general mycobacterial metabolism. 
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Annexes 
1. Transformation 
1.1. Preparation of Competent Cells 
1.1.1. SOB Medium 
Reagent Amount per litter Final concentration 
Tryptone 20 g 2% 
Yeast extract 5 g 0.5% 
NaCl 0.5 g 0.05% 
KCl 186 mg 2.5 mM 
MgCl2 2 M 2.5 mL 5 mM 
The pH was adjusted to 7. The solution was autoclaved and MgCl2 was added only after 
cooling down the solution. 
1.1.2. RF1 Solution 
Reagent Amount utilized Final concentration 
RbCl  3.02 g 100 mM 
CH3CO2K  7.36 g 30 mM 
CaCl2  0.32 g 10 mM 
MnCl2  1.19 g 50 mM 
Glycerol  0.05 g 15% 
The reagents were added in sequential order to avoid precipitation. The pH was adjusted 
to 5.8 exactly, with acetic acid, once again to avoid precipitation of the reagents. Water 
was added to a total volume of 250 mL and the solution was filter sterilized. 
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1.1.3. RF2 Solution 
Reagent Amount utilized Final concentration 
MOPS  0.10 g 10 mM 
RbCl  0.06 g 10 mM 
CaCl2  0.48 g 75 mM 
Glycerol  0.01 g 15% 
The solution’s pH was adjusted to 6.8-7. Water was added to a final volume of 50 mL 
and the solution was filter sterilized. 
Cells were grown in SOB medium supplemented with MgCl2. Cells were harvested by 
centrifugation at O.D.610=0.3-0.4, 3000 r.p.m., 15 min, at 4ºC, following a 15 min 
incubation on ice. Cells pellet was ressuspended in 8 mL RF1 solution and incubated 
15 min on ice. The suspension was once more centrifuged; the cell pellet was 
ressuspended in 2 mL of RF2 solution and incubated 15 min on ice. 100 µL aliquots 
were frozen at -80ºC. 
1.1.4. 10x Stock Salt Solution 
Reagent Amount utilized Final concentration 
KCl 0.18 g 240 mM 
MgCl2 2 g 210 mM 
MgSO4 2.46 g 200 mM 
Glucose filter sterilized 2 g 111 mM 
MQ water was added to a final volume of 100 mL. 
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1.2. Transformation 
The transforming DNA (10 µL of ligation) was added to the competent cells. The tubes 
were swirled gently to mix their contents and stored on ice for 20 minutes. The tubes ere 
then transferred for exactly 45 seconds to a preheated 42ºC water bath and .rapidly 
cooled on ice for 1-2 minutes. 500 µL of LB medium, with 10% salt solution, was 
added to the cells. The cultures were incubated at 37ºC for 45 minutes, to allow the 
bacteria to recover and to express the antibiotic resistance marker encoded by the 
plasmid. The appropriate volume (up to 200 µL per 90 mm plate) of transformed 
competent cells was transferred onto agar LB medium containing the suitable antibiotic 
(when working with pGEMT cloning vector 100 μl of each transformation culture was 
plated onto LB/ampicillin/IPTG/X-Gal plates). Plates were incubated at 37°C. 
2. Agarose Gel Electrophoresis 
2.1. TAE 50x 
Reagent Amount per liter Final concentration 
Tris base 242 g 2 M 
Acetic acid 57.1 mL 2 M 
Aqueous solution of EDTA 0.5 mM pH8 100 mL 0.05 M 
Tris (Merck) was dissolved in the aqueous solution of EDTA (Merck) while heating the 
mix. Acetic acid was added (José M. Vaz Pereira). pH was adjusted to 8 with NaOH 
5 M. H2O was added to a final volume of 1 L. 
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2.2. Agarose Gel (1% or 2%) 
Reagent Amount utilized Final concentration 
Agarose 1.5 g 1% 
 3 g 2% 
TAE1x 150 mL 1x 
Agarose (Molecular Biology Grade Bioron for electrophoresis) was dissolved in TAE 
buffer 1x, heated to boiling point and swirled to facilitate dissolution. The mix was 
cooled down to 60°C, ethidium bromide (10 mg/mL stock solution) was then added to a 
final concentration of 0.5 µg/ml (8 µL). The solution was stirred to disperse the 
ethidium bromide, poured slowly into the gel rack, the combs were inserted and the gel 
was left to gelate. The gel was run at 4v/cm for 30min, for 1% gel, and for 45 min for 
2% gel. 
As described in Sambrook & Russel (2001) chapter 5, protocol 1 and 2. 
3. 1.2% Formaldehyde Agarose Gel Electrophoresis 
3.1. 10x Formaldehyde Agarose Gel Buffer 
Reagent Amount utilized Final concentration 
MOPS (free acid)  20.93 g 200 mM 
Sodium acetate  2.06 g 50 mM 
EDTA  1.86 g 10 mM 
 
pH was adjusted to 7.0 with NaOH. 
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3.2. 1x Formaldehyde Agarose Gel Running Buffer 
Reagent Amount utilized Final concentration 
10x Formaldehyde Agarose gel buffer  50 mL 1x 
37% (12.3 M) formaldehyde  10 mL 123 mM 
RNase-free water  440 mL - 
3.3. 5X RNA Loading Buffer 
Reagent Amount utilized Final concentration 
Saturated aqueous bromophenol blue solution  16 µL - 
EDTA 500 mM, pH 8.0  80 µL 4 mM 
Formaldehyde 37% (12.3 M)  720 µL 880 mM 
Glycerol 100% 2 mL 20% 
Formamide  3084 µL 30.84% 
10x Formaldehyde Agarose gel buffer  4 mL 4x 
 
RNase-free water to was added to a final volume of 10 mL 
0.6 g of agarose were dissolved in 5 mL of 10x Formaldehyde Agarose Gel Buffer and 
45 mL of RNase free water, the solution was heated to boiling point and swirled to 
facilitate dissolution. The mix was cooled down to 60°C. 1.8 ml of 37% formaldehyde 
and ethidium bromide (10 mg/mL stock solution) to final concentration of 0.5 µg/ml 
(3 µL) were added in a fume hood. The solution was stirred and poured slowly into the 
gel rack, the comb was inserted and the gel was left to gelate. Prior to running the gel it 
was equilibrated in 1x Formaldehyde Agarose gel running buffer for 30 min. 
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4. Sodium Dodecylsulfate Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
4.1. Resolving Gel (12%) 
Reagent Amount utilized Final concentration 
Acrylamide/Bis, 37.5:1 mixture (30%T, 
2.67% C) (Biorad)  
2 mL  12% 
H2O  1.7 mL - 
1.5 M Tris-HCl, pH 8.8  1.25 mL 0.4 M 
SDS 10% (w/v)  50 µL 0.1% 
Just before pouring add catalysts 
TEMED  5 l ND* 
Ammonium Persulfate (APS) 10%  (w/v) 30 l 0.06% 
Swirl gently to initiate polymerization 
*Not determined 
4.2. Stacking Gel (4%) 
Reagent Amount utilized Final concentration 
Acrylamide/Bis, 37.5:1 mixture (30%T, 
2.67% C) (Biorad)  
 325 µL  4% 
H2O  1.525 mL - 
1.5 M Tris-HCl, pH 8.8  625 µL 0.4 M 
SDS 10% (w/v) 25 µL 0,1% 
Just before pouring add catalysts: 
TEMED  5 l ND* 
Ammonium Persulfate (APS) 10% (w/v) 30 l 0,12% 
Swirl gently to initiate polymerization 
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4.3. Sample Buffer (SDS Reducing Buffer) 
Reagent Amount utilized Final concentration 
H2O  3.55 mL  - 
0.5 M Tris-HCl, pH 6.8  1.25 mL 0.06 M 
Glycerol  2.5 mL 0.26% 
SDS 10% (w/v)  2.0 mL 2.1% 
Bromophenol blue 0.5%(w/v)  0.2 mL  0.01% 
 
4.4. 10x Running Buffer, pH 8.3 
Reagent Amount per liter Final concentration 
Tris base  30.3 g 0.25 M 
Glycine  144.0 g 1.92 M 
SDS  10.0 g 10% 
The reagents were dissolved and the total volume brought up to 1 L with water. This 
solution pH cannot be adjusted with acid or base. 
4.5. Coomassie Stain 
Reagent Amount per litter Final concentration 
Coomassie R-250 1 g  1% 
Glacial acetic acid  100 mL 10% (v) 
Methanol 400 mL 40% (v) 
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100 mL of glacial acetic acid were added to 500 mL of MQ H2O. Subsequently 500 mL 
of methanol were added. Finally 1 g of Coomassie dye was added the mixture was 
swirled and then filtered to remove particulates. 
4.6. Destaining Solution 
Reagent Amount per litter Final concentation 
Methanol 250 mL 25% (v) 
Glacial acetic acid 75 mL 7.5% (v) 
 
250 mL of glacial acetic acid were added to 675 mL of MQ H2O and then 500 mL of 
methanol were added to the mixture. 
The glass cassette and casting stand were assembled. Resolving gel solution was 
prepared by combining all reagents and poured into the glass cassette 1 cm below the 
comb teeth level. The solution was overlaid with buthanol and left to polymerize for 
30 min. The gel surface was completely rinsed with water and traces of water were 
removed with a piece of paper. The resolving gel solution was prepared by combining 
all reagents. The solution was poured into the cassette, the combs were inserted and the 
gel was left to polymerize for 30 min. After the stacking gel polymerization, the combs 
were removed; the tank was assembled, loaded and run at 200 V (constant V) for 
45 min. 
Samples were prepared by adding an equal volume of 2SDS sample buffer with 5% β-
Mercaptoethanol to the sample (still on ice) and were then incubated at 95C for 5 min. 
